Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

NCT01612299 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding was withdrawn for this study by the sponsor.

Conditions

Renal Transplant

Interventions

DRUG: Zortress® /Everolimus

Sponsor

University of Kentucky